Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides

scientific article published on February 2006

Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1747-0285.2006.00349.X
P932PMC publication ID3252236
P698PubMed publication ID16492164
P5875ResearchGate publication ID7285433

P50authorRobert E. W. HancockQ53441913
Linda RehaumeQ56811126
P2093author name stringRobert S Hodges
Adriana I Vasil
Michael L Vasil
Jane L Burns
Yuxin Chen
Colin T Mant
P2860cites workAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Q29547675
Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix.Q30330002
Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopyQ30595444
Animal antimicrobial peptides: an overviewQ33638713
Reviving the antibiotic miracle?Q72353506
Peptide antibioticsQ73073957
A novel method to measure self-association of small amphipathic molecules: temperature profiling in reversed-phase chromatographyQ73246661
Relationship of sidechain hydrophobicity and alpha-helical propensity on the stability of the single-stranded amphipathic alpha-helixQ73510301
Temperature profiling of polypeptides in reversed-phase liquid chromatography. I. Monitoring of dimerization and unfolding of amphipathic alpha-helical peptidesQ78753264
Temperature profiling of polypeptides in reversed-phase liquid chromatography. II. Monitoring of folding and stability of two-stranded alpha-helical coiled-coilsQ78753268
All-D amino acid-containing channel-forming antibiotic peptidesQ33643488
Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptidesQ33789716
Antimicrobial peptide therapeutics for cystic fibrosisQ33883742
Host-defense antimicrobial peptides: importance of structure for activityQ34123205
The crisis in antibiotic resistanceQ34314442
Pseudomonal infection in cystic fibrosis: the battle continuesQ34358536
Antimicrobial peptides: premises and promisesQ34369795
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic indexQ34432501
Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S.Q34623545
Temperature selectivity in reversed-phase high performance liquid chromatographyQ34865944
Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for controlQ36114466
Antimicrobial peptides: new candidates in the fight against bacterial infectionsQ36120089
Current guidelines for the treatment of severe pneumonia and sepsisQ36231604
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment optionsQ36268383
Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effectsQ37348516
Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its managementQ38007627
Lipids of mitochondriaQ38148540
Proton electrochemical gradient in Escherichia coli cells and its relation to active transport of lactoseQ39237347
N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activityQ39470734
Specificity of lipid-protein interactions as determined by spectroscopic techniquesQ39494730
Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayersQ39622704
Electrically gated ionic channels in lipid bilayersQ39625257
Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteriaQ40144766
In vitro uptake and stability study of pVEC and its all-D analogQ40652166
Cationic peptides: a new source of antibioticsQ41714967
All-D-cecropin B: synthesis, conformation, lipopolysaccharide binding, and antibacterial activityQ43593605
'Detergent-like' permeabilization of anionic lipid vesicles by melittinQ43737327
Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutionsQ44271454
Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptidesQ44276478
Structure–activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin SQ44415329
Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.Q44889398
Optimum concentration of trifluoroacetic acid for reversed-phase liquid chromatography of peptides revisitedQ45022643
All-D-enantiomers of beta-amyloid exhibit similar biological properties to all-L-beta-amyloids.Q46031773
Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosa.Q46723218
Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteriaQ47907289
Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.Q50518048
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranesQ50787783
Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity.Q52534879
Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide.Q52537084
D-cecropin B: proteolytic resistance, lethality for pathogenic fungi and binding properties.Q52582319
P433issue2
P921main subjectenantiomerQ494483
antimicrobial peptideQ1201508
P304page(s)162-173
P577publication date2006-02-01
P1433published inChemical Biology and Drug DesignQ15749458
P1476titleComparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides
P478volume67

Reverse relations

cites work (P2860)
Q33584712"Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa
Q34823180A D-peptide analog of the second extracellular loop of claudin-3 and -4 leads to mislocalized claudin and cellular apoptosis in mammary epithelial cells
Q30847307A retro-inverso cell-penetrating peptide for siRNA delivery.
Q37825833Alpha-helical cationic antimicrobial peptides: relationships of structure and function
Q37424896An antibacterial and absorbable silk-based fixation material with impressive mechanical properties and biocompatibility
Q35687730Anti-tuberculosis activity of α-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37.
Q38920223Beyond conventional antibiotics - New directions for combination products to combat biofilm
Q37778941Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold
Q48112477Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability
Q44520859D-Cateslytin, a new antimicrobial peptide with therapeutic potential
Q42318156D-form KLKLLLLLKLK-NH2 peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components
Q92219969De Novo Designed Amphipathic α-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii
Q39162082Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa
Q33897986Discovery of a small peptide from combinatorial libraries that can activate the plant immune system by a jasmonic acid signaling pathway
Q28478343Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival
Q92900106Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15
Q37313642Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides
Q37385746Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides
Q39202053Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1.
Q34809662Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications
Q54282937Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo.
Q56483985HPLC Analysis and Purification of Peptides
Q44276923HPLC analysis and purification of peptides
Q33926906Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides
Q42251963Improved protease stability of the antimicrobial peptide Pin2 substituted with D-amino acids.
Q92377294In silico design and optimization of selective membranolytic anticancer peptides
Q42058965In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens
Q39788897Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides
Q44385177Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides
Q42612783New linear antiplasmodial peptides related to angiotensin II.
Q40266754Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Q41907555Novel method to identify the optimal antimicrobial peptide in a combination matrix, using anoplin as an example
Q46628699Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides
Q92823732Peptide-Based Efflux Pump Inhibitors of the Small Multidrug Resistance Protein from Pseudomonas aeruginosa
Q40185116Preliminary investigations into developing all-D Omiganan for treating Mupirocin-resistant MRSA skin infections.
Q101137934Preparation, Characterization and Pharmacokinetic study of N-Terminal PEGylated D-form Antimicrobial Peptide OM19r-8
Q41897373Preparative reversed-phase high-performance liquid chromatography collection efficiency for an antimicrobial peptide on columns of varying diameters (1mm to 9.4mm I.D.).
Q57056760Profiling antimicrobial peptides from the medical maggot Lucilia sericata as potential antibiotics for MDR Gram-negative bacteria
Q34713859Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as desig
Q57177969Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A
Q42237870Role of helicity on the anticancer mechanism of action of cationic-helical peptides.
Q35758832Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides
Q48242962Role of positively charged residues on the polar and non-polar faces of amphipathic α-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens.
Q57177960Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers
Q35017565Structure-guided RP-HPLC chromatography of diastereomeric α-helical peptide analogs substituted with single amino acid stereoisomers
Q38964531Synthesis of composites SBA-15 mesoporous particles carrying oxytocin and evaluation of their properties, functions, and in vitro biological activities
Q47118800Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection
Q35905605The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
Q37954604The potential of antimicrobial peptides as biocides
Q53473484Tryptophan as a probe to study the anticancer mechanism of action and specificity of α-helical anticancer peptides.

Search more.